8-K - Castle Biosciences, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On January 11, 2026, Castle Biosciences, Inc. (the “Company”) issued a press release announcing certain prelimina

Financial Results

7.01

of this Current Report on Form 8-K, including Exhibit 99.2, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to t

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release issued January 1 1 , 202 6 . 99.2 Slide presentation. 104 Inline

Exhibits Only

Source Document

Exhibits (3)

8-K

99.1

EX-99.1

99.2

EX-99.2